Search filters

List of works by Vicky Makker

A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor–Positive Advanced or Recurrent Endometrial Cancer

scientific article published on 10 December 2024

A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer

scientific article published on 01 July 2018

A Review of Immune Checkpoint Blockade Therapy in Endometrial Cancer

scientific article published on 01 March 2020

A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study).

scientific article published on 07 September 2016

A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer

scientific article published on 17 January 2020

A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel

scientific article published on 9 March 2017

A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers

scientific article published on 30 October 2020

A prospective study of quality of life in patients undergoing pelvic exenteration: interim results

scientific article

A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study

scientific article published on 23 December 2018

A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma

scientific article published on 27 August 2008

An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma

scientific article published on 28 January 2016

Brain metastases in patients with low-grade endometrial carcinoma

scientific article published on 26 October 2018

Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation

scientific article published on 6 September 2017

Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation status

scientific article published on 18 May 2019

Breaking New Ground in the Treatment of Advanced Endometrial Cancer

scientific article published on 01 June 2019

Central retinal vein occlusion in the setting of fibroblast growth factor receptor inhibition

scientific article published in 2022

Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer

scientific article published on 01 August 2018

Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer

scientific article published on 19 November 2019

Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma

scientific article published on 30 July 2014

Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinoma

scientific article published on 10 October 2018

Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer.

scientific article

Corrigendum to "Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation" [Gynecol. Oncol. Rep. 22 (2017) 9-12].

scientific article published on 29 September 2017

Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade

scientific article published on 22 November 2018

Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer

scientific article

First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors

scientific article published on 08 May 2019

Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I–II papillary serous endometrial cancer ⬇️

scientific article published on July 28, 2012

From Burnout to Resilience: An Update for Oncologists

scientific article published on 01 May 2018

Germline drivers of gynecologic carcinosarcoma (2274)

scientific article published in September 2023

Germline drivers of gynecologic carcinosarcomas

scientific article published in July 2023

Getting serious about serous endometrial cancer: should we give chemotherapy in non-invasive cases?

scientific article published on 20 July 2020

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

scientific article published on 25 March 2020

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

scientific article published on 13 March 2020

Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial

scientific article published on 25 March 2019

Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers

scientific article published on 20 October 2020

Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy

scientific article published on 31 August 2018

Myocarditis with tremelimumab plus durvalumab combination therapy for endometrial cancer: A case report.

scientific article published in June 2018

New therapies for advanced, recurrent, and metastatic endometrial cancers.

scientific article published on 2 December 2017

Next-generation sequencing based detection of germline and somatic alterations in a patient with four metachronous primary tumors.

scientific article published on 18 April 2018

Nonbacterial thrombotic endocarditis with embolic cerebral vascular accidents in a patient with advanced, recurrent clear cell carcinoma of the ovary: A case report

scientific article published on 17 March 2016

Optimizing immunotherapy for gynecologic cancers

scientific article published on 01 February 2020

Patterns of FIRST recurrence of stage IIIC1 endometrial cancer with no PARAAORTIC nodal assessment

scientific article published on 02 October 2018

Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy

scientific article

Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer

scientific article published on 11 September 2020

Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway

scientific article published on 27 December 2019

Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors.

scientific article published on 20 March 2018

Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors

scientific article published on 21 January 2020

Phase II evaluation of dalantercept in the treatment of persistent or recurrent epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study

scientific article published on 03 July 2018

Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study 0229N

scientific article

Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer

scientific article published on 12 November 2019

Phase Ib Study of Binimetinib with Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer: Final Results, Potential Biomarkers, and Extreme Responders.

scientific article

Placental site trophoblastic tumor: Analysis of presentation, treatment, and outcome ⬇️

scientific article published on December 26, 2012

Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer ⬇️

scientific article published on November 15, 2012

Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival ⬇️

scientific article published on February 15, 2013

Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications

scientific article published in March 2013

Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience

Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion

scientific article published on 04 October 2013

Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node Mapping

scientific article published on 3 March 2017

Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node Mapping

scientific article published on 21 May 2015

Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study

scientific article

Treatment of advanced or recurrent endometrial carcinoma with doxorubicin in patients progressing after paclitaxel/carboplatin: Memorial Sloan-Kettering Cancer Center experience from 1995 to 2009.

scientific article published on June 2013

Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation

scientific article published in November 2013

Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study

scientific article published on April 2016

Paulina is supported by:

About Paulina

Help